$EWTX

$39.53 +$0.36 (0.92%) Close

$EWTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$EWTX Management Team

Dr. Behrad Derakhshan

Chief Operating Officer

Age 45

Compensation $2.896M USD

Sex Male

Mr. Robert Blaustein

Chief Development Officer

Age 64

Compensation -

Sex Male

Dr. Joanne Donovan

Chief Medical Officer

Age 68

Compensation $2.924M USD

Sex Female

Dr. Badreddin Edris

Independent Director

Co-Founder

Age 37

Compensation $296.0K USD

Sex Male

Dr. Peter Thompson

Independent Chairman of the Board

Co-Founder

Age 65

Compensation $326.9K USD

Sex Male

Dr. Kevin Koch

President

Chief Executive Officer

Director

Age 64

Compensation $7.601M USD

Sex Male

Dr. Alan Russell

Chief Scientific Officer

Director

Co-Founder

Age 55

Compensation $2.459M USD

Sex Male

Mr. John Moore

General Counsel

Age 60

Compensation -

Sex Male

Mr. Michael Nofi

Chief Financial Officer

Age 54

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Behrad Derakhshan Chief Operating Officer	45	$2.896M USD	Male
Mr. Robert Blaustein Chief Development Officer	64	-	Male
Dr. Joanne Donovan Chief Medical Officer	68	$2.924M USD	Female
Dr. Badreddin Edris Independent Director Co-Founder	37	$296.0K USD	Male
Dr. Peter Thompson Independent Chairman of the Board Co-Founder	65	$326.9K USD	Male
Dr. Kevin Koch President Chief Executive Officer Director	64	$7.601M USD	Male
Dr. Alan Russell Chief Scientific Officer Director Co-Founder	55	$2.459M USD	Male
Mr. John Moore General Counsel	60	-	Male
Mr. Michael Nofi Chief Financial Officer	54	-	Male

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

6 of 6

stated in the proxy; 2 not stated

Average tenure

5.6 years

from year joined

CEO also chairs the board

Peter Thompson

Director	Age	On board	Independent	Committees	Other public boards	Pay
Peter Thompson Board chair	66	2017 9 years	Independent	None stated	Sionna Therapeutics Inc., Corvus Pharmaceuticals, Inc., ARS Pharmaceuticals Inc.	Not stated
Badreddin Edris	39	2021 5 years	Independent	Compensation · Chair	None stated	Not stated
Jonathan Root	66	2019 7 years	Independent	Audit Nominating & Corporate Governance · Chair	None stated	Not stated
Christopher Martin	50	2025 1 year	Independent	Nominating & Corporate Governance	None stated	Not stated
Arlene Morris	74	2024 2 years	Independent	Audit Compensation	Palatin Technologies	Not stated
Alan Russell Executive officer	56	2017 9 years	Not stated	None stated	None stated	Not stated
Jonathan Fox	69	2023 3 years	Independent	Nominating & Corporate Governance	None stated	Not stated
Kevin Koch CEO	65	2017 9 years	Not stated	None stated	None stated	Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$EWTX Management Team

Dr. Behrad Derakhshan

Mr. Robert Blaustein

Dr. Joanne Donovan

Dr. Badreddin Edris

Dr. Peter Thompson

Dr. Kevin Koch

Dr. Alan Russell

Mr. John Moore

Mr. Michael Nofi

Board of Directors

Related-party transactions

No related-party transactions disclosed